Clinical Trials Directory

Trials / Completed

CompletedNCT00764374

A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
412 (actual)
Sponsor
Astellas Pharma Inc · Industry
Sex
All
Age
20 Years – 79 Years
Healthy volunteers
Not accepted

Summary

To examine the safety and efficacy of Z-338 (YM443) after long-term administration in patients with functional dyspepsia, and also to examine the pattern of long-term administration.

Conditions

Interventions

TypeNameDescription
DRUGYM443oral

Timeline

Start date
2008-08-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2008-10-02
Last updated
2014-10-29

Locations

4 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT00764374. Inclusion in this directory is not an endorsement.

A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia (NCT00764374) · Clinical Trials Directory